XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net income $ 885 $ 599
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Net gain from securities transactions (1,133) (1,290)
Purchases of securities (20) (1,519)
Proceeds from sales of securities 3,330 715
Payments to cover securities sold, not yet purchased (1,913) (459)
Proceeds from securities sold, not yet purchased 816 2,141
Changes in receivables and payables relating to securities transactions (416) (858)
Changes in derivative assets and liabilities 85 (125)
Depreciation and amortization 122 127
Deferred taxes 57 (18)
Other, net 26 10
Changes in other operating assets and liabilities 81 126
Net cash provided by (used in) operating activities 1,920 (551)
Cash flows from investing activities:    
Capital expenditures (55) (47)
Turnaround expenditures (15) (1)
Acquisition of businesses, net of cash acquired   (20)
Proceeds from sale of investments 107 182
Other, net 1 2
Net cash provided by investing activities 38 116
Cash flows from financing activities:    
Investment segment contributions from non-controlling interests 2 40
Partnership contributions 178 182
Partnership distributions (1)  
Dividends and distributions to non-controlling interests in subsidiaries (36)  
Proceeds from Holding Company senior unsecured notes   750
Repayments of Holding Company senior unsecured notes (500) (750)
Proceeds from subsidiary borrowings 32 177
Repayments of subsidiary borrowings (97) (180)
Other, net (13) (5)
Net cash (used in) provided by financing activities (435) 214
Effect of exchange rate changes on cash and cash equivalents and restricted cash and restricted cash equivalents 2 6
Net increase (decrease) in cash and cash equivalents and restricted cash and restricted cash equivalents 1,525 (215)
Cash and cash equivalents and restricted cash and restricted cash equivalents, beginning of period 4,436 3,291
Cash and cash equivalents and restricted cash and restricted cash equivalents, end of period $ 5,961 $ 3,076